DOI Prefix : 10.9780 | Journal DOI : 10.9780/22307850
Scroll to Top

Volume : IV, Issue : XII, January - 2015

DEVELOPMENT OF INDUCIBLE DRUG RESISTANCE TO AMOXICILLIN AND CEPHALEXIN IN A PROBIOTIC STRAIN OF LACTOBACILLI

Anjali A Tiwari, -

DOI : 10.9780/22307850, By : Laxmi Book Publication

Abstract :

Probiotic must be able to benefit on host through activity in human body. Lactobacillus organisms are normal inhabitants of the human intestine and vagina. They are the main ones that produce lactic acid in the digestive tract, which is important for overall health. For the prevention of intestinal disorders, probiotics can be rendered multidrug resistance to survive in the presence of antibiotics. Isolation and identification, detection and development of antibiotic resistecein this strains of lactobacillus species from commercially available probiotics and for this antibiotic susceptibility and Development of inducible drug resistance to amoxicillin and cephalexin were done and found that isolated probiotic strain was Lactobacillus rhamnosus. It is a Gram positive, nonmotile, non sporing, rod shaped bacteria. The size of colonies of Lactobacillus rhamnosus on MRS medium was of 1mm in diameter, circular, pale yellow, concave elevation, opaque and with a smooth surface and various sugar test also performed and from this result it is concluded A new strain of Lactobacillus rhamnosus that developed was resistant to amoxicillin and cephalexin at a concentration of 70μg/mL.

Keywords :


Article :


Cite This Article :

Anjali A Tiwari, -(2015). DEVELOPMENT OF INDUCIBLE DRUG RESISTANCE TO AMOXICILLIN AND CEPHALEXIN IN A PROBIOTIC STRAIN OF LACTOBACILLI. Indian Streams Research Journal, Vol. IV, Issue. XII, DOI : 10.9780/22307850, http://isrj.org/UploadedData/5827.pdf

References :

  1. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  2. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  3. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  4. 526.
  5. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  6. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  7. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  8. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  9. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  10. Dairy J 8: 487-490.
  11. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  12. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  13. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  14. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  15. 2, pdf.
  16. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  17. 1046-9.
  18. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  19. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  20. Microbiol, 33: 1433
  21. 526.
  22. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  23. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  24. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  25. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  26. 2, pdf.
  27. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  28. 526.
  29. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  30. 2, pdf.
  31. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  32. future prospects. Gut pathogens, 1(19): 1-12.
  33. Microbiol, 33: 1433
  34. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  35. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  36. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  37. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  38. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  39. Microbiol, 33: 1433
  40. 2, pdf.
  41. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  42. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  43. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  44. 2, pdf.
  45. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  46. future prospects. Gut pathogens, 1(19): 1-12.
  47. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  48. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  49. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  50. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  51. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  52. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  53. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  54. future prospects. Gut pathogens, 1(19): 1-12.
  55. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  56. 526.
  57. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  58. future prospects. Gut pathogens, 1(19): 1-12.
  59. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  60. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  61. 526.
  62. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  63. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  64. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  65. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  66. future prospects. Gut pathogens, 1(19): 1-12.
  67. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  68. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  69. Dairy J 8: 487-490.
  70. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  71. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  72. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  73. 1046-9.
  74. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  75. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  76. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  77. 1046-9.
  78. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  79. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  80. future prospects. Gut pathogens, 1(19): 1-12.
  81. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  82. future prospects. Gut pathogens, 1(19): 1-12.
  83. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  84. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  85. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  86. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  87. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  88. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  89. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  90. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  91. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  92. future prospects. Gut pathogens, 1(19): 1-12.
  93. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  94. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  95. 1046-9.
  96. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  97. future prospects. Gut pathogens, 1(19): 1-12.
  98. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  99. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  100. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  101. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  102. Dairy J 8: 487-490.
  103. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  104. future prospects. Gut pathogens, 1(19): 1-12.
  105. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  106. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  107. 1046-9.
  108. future prospects. Gut pathogens, 1(19): 1-12.
  109. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  110. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  111. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  112. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  113. Dairy J 8: 487-490.
  114. 2, pdf.
  115. Dairy J 8: 487-490.
  116. future prospects. Gut pathogens, 1(19): 1-12.
  117. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  118. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  119. future prospects. Gut pathogens, 1(19): 1-12.
  120. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  121. future prospects. Gut pathogens, 1(19): 1-12.
  122. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  123. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  124. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  125. future prospects. Gut pathogens, 1(19): 1-12.
  126. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  127. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  128. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  129. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  130. Microbiol, 33: 1433
  131. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  132. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  133. future prospects. Gut pathogens, 1(19): 1-12.
  134. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  135. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  136. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  137. 1046-9.
  138. future prospects. Gut pathogens, 1(19): 1-12.
  139. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  140. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  141. 1046-9.
  142. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  143. 2, pdf.
  144. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  145. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  146. future prospects. Gut pathogens, 1(19): 1-12.
  147. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  148. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  149. Microbiol, 33: 1433
  150. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  151. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  152. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  153. 2, pdf.
  154. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  155. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  156. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  157. Dairy J 8: 487-490.
  158. 2, pdf.
  159. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  160. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  161. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  162. Dairy J 8: 487-490.
  163. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  164. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  165. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  166. future prospects. Gut pathogens, 1(19): 1-12.
  167. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  168. Microbiol, 33: 1433
  169. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  170. future prospects. Gut pathogens, 1(19): 1-12.
  171. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  172. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  173. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  174. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  175. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  176. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  177. Dairy J 8: 487-490.
  178. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  179. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  180. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  181. 2, pdf.
  182. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  183. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  184. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  185. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  186. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  187. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  188. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  189. 526.
  190. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  191. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  192. future prospects. Gut pathogens, 1(19): 1-12.
  193. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  194. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  195. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  196. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  197. Dairy J 8: 487-490.
  198. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  199. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  200. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  201. future prospects. Gut pathogens, 1(19): 1-12.
  202. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  203. future prospects. Gut pathogens, 1(19): 1-12.
  204. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  205. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  206. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  207. Dairy J 8: 487-490.
  208. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  209. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  210. future prospects. Gut pathogens, 1(19): 1-12.
  211. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  212. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  213. 526.
  214. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  215. future prospects. Gut pathogens, 1(19): 1-12.
  216. 1046-9.
  217. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  218. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  219. future prospects. Gut pathogens, 1(19): 1-12.
  220. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  221. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  222. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  223. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  224. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  225. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  226. 1046-9.
  227. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  228. Dairy J 8: 487-490.
  229. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  230. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  231. Dairy J 8: 487-490.
  232. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  233. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  234. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  235. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  236. Dairy J 8: 487-490.
  237. 2, pdf.
  238. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  239. Dairy J 8: 487-490.
  240. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  241. Microbiol, 33: 1433
  242. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  243. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  244. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  245. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  246. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  247. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  248. 2, pdf.
  249. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  250. 1046-9.
  251. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  252. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  253. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  254. 2, pdf.
  255. 526.
  256. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  257. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  258. 2, pdf.
  259. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  260. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  261. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  262. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  263. 2, pdf.
  264. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  265. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  266. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  267. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  268. future prospects. Gut pathogens, 1(19): 1-12.
  269. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  270. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  271. 2, pdf.
  272. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  273. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  274. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  275. 2, pdf.
  276. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  277. Microbiol, 33: 1433
  278. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  279. 1046-9.
  280. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  281. Microbiol, 33: 1433
  282. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  283. future prospects. Gut pathogens, 1(19): 1-12.
  284. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  285. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  286. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  287. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  288. 526.
  289. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  290. 2, pdf.
  291. 1046-9.
  292. Dairy J 8: 487-490.
  293. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  294. future prospects. Gut pathogens, 1(19): 1-12.
  295. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  296. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  297. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  298. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  299. 526.
  300. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  301. 1046-9.
  302. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  303. 526.
  304. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  305. Microbiol, 33: 1433
  306. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  307. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  308. Microbiol, 33: 1433
  309. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  310. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  311. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  312. Microbiol, 33: 1433
  313. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  314. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  315. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  316. future prospects. Gut pathogens, 1(19): 1-12.
  317. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  318. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  319. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  320. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  321. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  322. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  323. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  324. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  325. future prospects. Gut pathogens, 1(19): 1-12.
  326. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  327. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  328. future prospects. Gut pathogens, 1(19): 1-12.
  329. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  330. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  331. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  332. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  333. Dairy J 8: 487-490.
  334. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  335. future prospects. Gut pathogens, 1(19): 1-12.
  336. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  337. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  338. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  339. 526.
  340. Dairy J 8: 487-490.
  341. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  342. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  343. future prospects. Gut pathogens, 1(19): 1-12.
  344. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  345. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  346. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  347. future prospects. Gut pathogens, 1(19): 1-12.
  348. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  349. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  350. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  351. Dairy J 8: 487-490.
  352. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  353. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  354. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  355. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  356. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  357. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  358. 2, pdf.
  359. 1046-9.
  360. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  361. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  362. future prospects. Gut pathogens, 1(19): 1-12.
  363. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  364. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  365. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  366. future prospects. Gut pathogens, 1(19): 1-12.
  367. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  368. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  369. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  370. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  371. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  372. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  373. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  374. 2, pdf.
  375. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  376. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  377. future prospects. Gut pathogens, 1(19): 1-12.
  378. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  379. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  380. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  381. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  382. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  383. Dairy J 8: 487-490.
  384. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  385. Microbiol, 33: 1433
  386. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  387. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  388. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  389. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  390. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  391. future prospects. Gut pathogens, 1(19): 1-12.
  392. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  393. future prospects. Gut pathogens, 1(19): 1-12.
  394. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  395. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  396. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  397. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  398. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  399. 526.
  400. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  401. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  402. 2, pdf.
  403. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  404. 2, pdf.
  405. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  406. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  407. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  408. 2, pdf.
  409. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  410. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  411. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  412. Dairy J 8: 487-490.
  413. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  414. 1046-9.
  415. future prospects. Gut pathogens, 1(19): 1-12.
  416. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  417. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  418. future prospects. Gut pathogens, 1(19): 1-12.
  419. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  420. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  421. Microbiol, 33: 1433
  422. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  423. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  424. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  425. future prospects. Gut pathogens, 1(19): 1-12.
  426. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  427. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  428. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  429. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  430. future prospects. Gut pathogens, 1(19): 1-12.
  431. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  432. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  433. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  434. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  435. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  436. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  437. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  438. future prospects. Gut pathogens, 1(19): 1-12.
  439. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  440. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  441. Dairy J 8: 487-490.
  442. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  443. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  444. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  445. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  446. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  447. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  448. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  449. future prospects. Gut pathogens, 1(19): 1-12.
  450. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  451. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  452. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  453. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  454. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  455. 2, pdf.
  456. future prospects. Gut pathogens, 1(19): 1-12.
  457. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  458. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  459. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  460. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  461. Dairy J 8: 487-490.
  462. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  463. future prospects. Gut pathogens, 1(19): 1-12.
  464. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  465. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  466. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  467. 1046-9.
  468. future prospects. Gut pathogens, 1(19): 1-12.
  469. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  470. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  471. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  472. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  473. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  474. 1046-9.
  475. 526.
  476. future prospects. Gut pathogens, 1(19): 1-12.
  477. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  478. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  479. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  480. 2, pdf.
  481. 526.
  482. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  483. 526.
  484. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  485. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  486. future prospects. Gut pathogens, 1(19): 1-12.
  487. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  488. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  489. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  490. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  491. 2, pdf.
  492. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  493. future prospects. Gut pathogens, 1(19): 1-12.
  494. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  495. future prospects. Gut pathogens, 1(19): 1-12.
  496. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  497. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  498. future prospects. Gut pathogens, 1(19): 1-12.
  499. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  500. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  501. 526.
  502. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  503. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  504. Microbiol, 33: 1433
  505. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  506. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  507. future prospects. Gut pathogens, 1(19): 1-12.
  508. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  509. Dairy J 8: 487-490.
  510. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  511. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  512. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  513. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  514. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  515. future prospects. Gut pathogens, 1(19): 1-12.
  516. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  517. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  518. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  519. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  520. 526.
  521. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  522. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  523. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  524. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  525. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  526. 1046-9.
  527. Microbiol, 33: 1433
  528. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  529. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  530. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  531. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  532. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  533. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  534. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  535. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  536. 1046-9.
  537. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  538. 526.
  539. 1046-9.
  540. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  541. 526.
  542. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  543. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  544. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  545. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  546. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  547. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  548. 2, pdf.
  549. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  550. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  551. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  552. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  553. Dairy J 8: 487-490.
  554. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  555. Microbiol, 33: 1433
  556. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  557. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  558. Microbiol, 33: 1433
  559. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  560. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  561. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  562. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  563. Dairy J 8: 487-490.
  564. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  565. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  566. Dairy J 8: 487-490.
  567. Saavedra JM, Bauman NA, Oung I, Perman JA and Yolken RH, (1994). Feeding of Bifidobacterium bifidum and
  568. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  569. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  570. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  571. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  572. Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med, 116: 353-357
  573. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  574. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  575. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  576. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  577. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  578. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  579. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  580. Microbiol, 33: 1433
  581. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  582. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  583. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  584. future prospects. Gut pathogens, 1(19): 1-12.
  585. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  586. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  587. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  588. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  589. future prospects. Gut pathogens, 1(19): 1-12.
  590. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  591. Microbiol, 33: 1433
  592. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  593. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  594. Arunachalam K, Gill HS and Chandra RK, (2000). Enhancement of natural immunity function by dietary
  595. Microbiol, 33: 1433
  596. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  597. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  598. Gill H S, and Guarner F, (2004). Probiotics and human health: a clinical perspective. Postgard Med J, 80: 516-526.
  599. 2, pdf.
  600. future prospects. Gut pathogens, 1(19): 1-12.
  601. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  602. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  603. consumption of Bifidobacterium lactis HN019. European J Clin Nutr, 54: 1-4.
  604. Culligan EP, Hill C, and Sleator RD, (2009). Probiotics and gastrointestinal disease: successes, problems, and
  605. future prospects. Gut pathogens, 1(19): 1-12.
  606. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  607. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  608. Microbiol, 33: 1433
  609. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  610. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  611. Gill, H.S. and Guarner F., (2004). Probiotics and human health: a clinical prespective. Postgard Med J, 80: 516-
  612. Hilton E, Isenberg HD, Alperstein P, France K and Borenstein MT, (1992). Ingestion of yogurt containing
  613. Microbiol, 33: 1433
  614. Streptococcus thermophilus to infants in hospital forprevention of diarrhoea and shedding of rotavirus. Lancet, 344:
  615. Tagg , J.R. and McGiven,(1971). Assay system for bacteriocines. Appl Microbial, 21,943.
  616. Collins JK, Thornton G and O’Sullivan GO, (1998). Selection of probiotic strains for human applications. Int
  617. future prospects. Gut pathogens, 1(19): 1-12.
  618. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  619. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part
  620. future prospects. Gut pathogens, 1(19): 1-12.
  621. Hilton E, Rindos P and Isenberg HD (1995): Lactobacillus GG vaginal suppositories and vaginitis. J Clin
  622. World Health Organization, (2004). http://www.who.int/info/healthinfo/globalburdendis ease/GBD report part

Article Post Production

    No data exists for the row/column.
Creative Commons License
Indian Streams Research Journal by Laxmi Book Publication is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at http://oldisrj.lbp.world/Default.aspx.
Permissions beyond the scope of this license may be available at http://oldisrj.lbp.world/Default.aspx
Copyright © 2014 Indian Streams Research Journal. All rights reserved
Looking for information? Browse our FAQs, tour our sitemap, or contact ISRJ
Read our Privacy Policy Statement and Plagairism Policy. Use of this site signifies your agreement to the Terms of Use